Researchers have created a simple and fast way to perform optoretinography, which monitors light-induced functional activity in the retina, the network of neurons at the back of our eyes that are in charge of detecting light and triggering vision.
According to Roche, the European Commission (EC) has approved Vabysmo (faricimab) for the treatment of diabetic macular edema (DME) and wet age-related macular degeneration (AMD).
Trukera Medical unveiled the first product under the new company name, the ScoutPro Osmolarity System. ScoutPro is the first and only portable osmometer in the United States.
The California Legislature recently passed AC 2236, an optometric surgery bill that, if signed into law, would expand optometrists’ scope of practice in California to include some scalpel and laser eye surgeries, as well as medication injections.
Researchers at the National Eye Institute (NEI) have developed a gene therapy that corrects cilia deficiencies in retinal cells affected by a particular type of Leber congenital amaurosis (LCA), a disease that causes blindness in early childhood.
The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) filing for NOV03 (perfluorohexyloctane) for the treatment of the signs and symptoms of dry eye disease, according to a joint press release from Bausch + Lomb and Novaliq.
TearLab has announced plans to strengthen its position in corneal health under the new name Trukera Medical.
According to a recent study by UT Southwestern researchers, people are more likely to develop primary open-angle glaucoma, the main cause of irreversible blindness worldwide, the earlier they have type 2 diabetes or hypertension in life.
At the National Institutes of Health, a surgical team treated advanced "dry" age-related macular degeneration (AMD), also known as geographic atrophy, by successfully implanting a patch of tissue generated from patient cells.
European Society of Cataract and Refractive Surgery (ESCRS) has adopted a first-of-its-kind vision and commitment toward sustainability and net-zero carbon emission starting from the 40th Congress of the ESCRS from 16-20 September in Milan, Italy.